By targeting flu-enabling protein, antibody may protect against wide-ranging strains: The findings could lead to a universal flu vaccine and more effective emergency treatments Science Daily
ABIVAX Reports Impressive 12-month Efficacy and Safety Data from ABX464 Ulcerative Colitis Maintenance Study at United European Gastroenterology Conference Business Wire